A claims data sample from Express Scripts shows that patients enrolling for health coverage under the Affordable Care Act (ACA) are more likely to use specialty drugs to treat HIV/AIDS or hepatitis C than those with coverage through employers. The results, which cover claims from the first 2 months of 2014, were reported April 9, 2014, by MedCity News.1
Experts noted that the results do not reflect late enrollment that caused the ranks signing up on state and federal exchanges to swell past 7 million, the original target for ACA enrollment from the Congressional Budget Office. Enrollment on the exchanges through the end of January was only 3.3 million, as reported by the US Department of Health and Human Services.2
It was no surprise that those with chronic conditions enrolled as early as possible, with younger, healthier consumers signing up closer to the deadline. “We all expected that the people who signed up by January and February would be a lot sicker than anyone else,” said Robert Lazsewski, a consultant to the insurance industry. “It will be a year before we know what we’ve got.”1
Express Scripts, one of the nation’s largest pharmacy benefit managers, analyzed more than 650,000 claims filed in January and February with 25 insurers, and compared them to claims filed by a subset of employer-based plans that Express Scripts oversees.
The analysis was based on total drug spending, including the portion paid by insurers and patients. Among the findings:
• HIV drugs accounted for more than 6 in every 1000 prescriptions, a rate 4 times that of employer plans.
• Sovaldi, an $84,000 treatment approved in December to treat hepatitis C, came in second for total spending, while it ranked eighth in the comparison group.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Mental Health Diagnoses, Care Challenges Rise Among US Youth, Report Finds
April 26th 2024While behavioral health care utilization has been rising, the treatment landscape has been worsening. New findings show that 20% of youths did not receive any form of treatment within 3 months of their initial behavioral health diagnosis.
Read More